Our results show that DI-10 reversed the effects of hyperglycemia in skeletal muscle by activating protein synthesis through the Akt/mTOR pathway and preventing protein degradation by downregulating Murf-1 and MAFbx through FoxO3 (Figure 8). Here, FOXO3 is linked to Hyperglycemia.